Market Insights

TC Economic Insight - The Week Ahead (November 24-28)

Let's find out how Economic Insight helps trading prep on the releease of Canada's GDP next Friday.
George Lam
,
11/21/2025

Market Insights

TC Economic Insight - The Week Ahead (NOV 17-21)

Eventually, the U.S. government reopens for business after the longest shutdown in history. Now, investors’ attention will turn to critical data on employment and inflation.
Kim Ming Lam
,
11/15/2025

Market Insights

Top Buzzing ranking 14th November - Applied Materials Inc

Using Trading Central's Market Buzz and looking into Top Buzzing ranking to find premarket moves, we have identified Applied Materials as an interesting choice.
Théo Ramos
,
11/14/2025

Market Insights

TC Economic Insight - The Week Ahead (NOV 10-14)

We are watching closely if the release of major U.S. inflation data, scheduled for Thursday (November 13), could be affected by the on-going government shutdown.
Kim Ming Lam
,
11/9/2025

Market Insights

Top Buzzing ranking Nov 4th - IDEXX Laboratories

Using Trading Central's Market Buzz for understanding stocks' variation, IDEXX Laboratories (IDXX) has been identified as an interesting choice.
Philippe Delabarre
,
11/4/2025

Market Insights

Top Buzzing ranking Oct 31st - Cloudflare

Using Trading Central's Market Buzz for understanding stocks' variation, Cloudflare has been identified as an interesting choice.
Philippe Delabarre
,
10/31/2025

Market Insights

TC Economic Insight - The Week Ahead (November 3-7)

As the Bank of England's rate decision nears, let's see how Economic Insight helps trading prep.
George Lam
,
10/31/2025

Expert Analyst

Fed Ends QT and Cuts Rates – What This Means for Liquidity and Risk Assets

Covering the Fed’s latest rate cut and plans for a QT pause, the implications for liquidity, and how investors might rotate into risk assets.
Luis Leon Guerrero
,
10/29/2025

Market Insights

Top Buzzing ranking Oct 29th - Regeneron Pharmaceuticals

Using Trading Central's Market Buzz for understanding stocks' variation, Regeneron Pharmaceuticals has been identified as an interesting choice.
Philippe Delabarre
,
10/29/2025
Previous
Next